PROAND ANTIANGIOGENIC FACTORS IN THE PATHOGENESIS OF EARLY PREGNANCY LOSSES. PART I. THE SPECIFIC FEATURES OF PROAND ANTIANGIOGENIC SERUM FACTORS IN EARLY PREGNANCY
- Authors: ZIGANSHINA M.M1, KRECHETOVA L.V1, VANKO L.V1, KHODZHAYEVA Z.S1, MUSIYENKO E.V1, SUKHIKH G.T1
-
Affiliations:
- Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia
- Issue: No 3 (2012)
- Pages: 14-19
- Section: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/246679
- ID: 246679
Cite item
Abstract
Full Text
About the authors
M. M ZIGANSHINA
Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia
Email: mmz@mail.ru
Moscow
L. V KRECHETOVA
Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of RussiaMoscow
L. V VANKO
Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of RussiaMoscow
Z. S KHODZHAYEVA
Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of RussiaMoscow
E. V MUSIYENKO
Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of RussiaMoscow
G. T SUKHIKH
Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of RussiaMoscow
References
- Бурлев В.А., Зайдиева З.С., Ильясова Н.А. Регуляция ангиогенеза гестационного периода // Пробл. репрод. - 2008. - № 3. - С. 15-22.
- Внутриутробное развитие человека / Под ред. А.П. Милованова, С.В. Савельева. - М.: Медицина для всех, - 2006.
- Лазюк Г.И. Тератология человека. - М.: Медицина, 1991.
- Ранние сроки беременности / Под ред. В.Е. Радзинского, А.А. Оразмурадова. - М.: Status Praesens, 2009.
- Bai S.X., Wang Y.L., Qin L. et al. Dynamic expression of matrix metalloproteinases (MMP-2,-9 and -14) and the tissue inhibitors of MMPs (TIMP-1,-2 and -3) at the implantation site during tubal pregnancy // Reproduction. - 2005. -№ 129. - P. 103-113.
- Bates D.O. Vascular endothelial growth factors and vascular permeability // Cardiovasc. Res. - 2010. - № 87. -P. 262-271.
- Burton G.I., Charnock-Jones D.S., Jauniaux E. Regulation of vascular growth and function in the human placenta // Reproduction. - 2009. - № 138. - P. 895-902.
- Douglas N.C., Tang H., Gomez R. et al. Vascular endothelial growth factor receptor 2 (VEGF-2) functions to promote uterine decidual angiogenesis during early pregnancy in the mouse // Endocrinology. - 2009. - № 150. - P. 3845-3854.
- Florio P., Gabbanini M., Borges L.E. et al. Activins and related proteins in the establishment of pregnancy // Reprod. Sci. -2010. - № 17. - P. 320-330.
- Forbes K., Westwood M. Maternal growth factor regulation of human placental development and fetal growth // J. Endocrinol. - 2010. - № 207. - P. 1-16.
- Gabhann F.M., Popel A.S. Model of competitive binding of vascular endothelial growth factor and placental growth factor to VEGF receptors on endothelial cells // Am. J. Physiol. Heart Circ. Physiol. 2004. - № 286. - P. 153-164.
- Kalkunte S.S., Mselle N.F., Norris W.E. et al. Vascular endothelial growth factor C facilitates immune tolerance and endovascular activity of human uterine NK cells at the maternal-fetal interface // J. Immunol. - 2009. - № 182. -P. 4085-4092.
- Lorquet S., Pequeux C., Berndt S. et al. Implication of VEGF receptor soluble forms, sVEGFR-1 and sVEGFR-2, in pathological angiogenesis // Abstracts of the 23rd Annual Meeting of the ESHRE, Lyon, France, 1-4 July, 2007. -P. 1174-1175.
- Molshkness T.A., Stouffer R.L., Burry K.A. Circulating levels of free and total vascular endothelial growth factor (VEGF)-A, soluble VEGF recepror-1 and -2, and angiogenin during ovarian stimulation in non-human primates and women // Hum. Reprod. - 2004. - № 19. - P. 822-830.
- Naruse K., Lash G.E., Innes B. et al. Localization of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitors for MMPs (TIMPs) in uterine natural killer cells in early human pregnancy // Hum. Reprod. - 2008. - Vol. 23, № 1. -P. 1-9.
- Olson M.W., Gervasi D.C., Mobashery S., Fridman R. Kinetic analysis of the binding of human matrix metalloproteinase-2 and -9 to tissue inhibitor of metalloproteinase (TIMP-1) and (TIMP-2) // J. Biol. Chem. - 1997. - № 272. -P. 29975-29983.
- Plaisier M., Streefland E., Koolwijk P. et al. Angiogenic growth factors and their receptors in first-trimester human deciduas of pregnancies further complicated by preeclampsia or fetal growth restriction // Reprod. Sci. - 2008. - № 15. -P. 720-726.
- Plaisier M., Dennert I., Rost E. et al. Decidual vascularization and the expression of angiogenic growth factors and proteases in first trimester spontaneous abortions // Hum. Reprod. - 2009. - Vol. 24. - P.185-197.
- Sugimoto H., Hamano Y., Charytan D. et al. Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induced proteinuria // J. Biol. Chem. - 2003. - № 278. -P. 12605-12608.
- Wang A., Rana S., Karumanchi S.A. Preeclampsia: the role of angiogenic factors in its pathogenesis // Physiology. - 2009. -№ 24. - P. 147-158.
- Wathen K-A., Tuutti E., Stenman U-H. et al. Maternal serum-soluble vascular endothelial growth factor receptor-1 in early pregnancy ending in preeclampsia or intrauterine growth retardation // J. Clin. Endocrinol. Metab. - 2006. -№ 91. - P. 180-184.
- Wulff C., Weigand M., Kreienberg R., Fraser H.M. Angiogenesis during primate placentation in health and disease // Reproduction. - 2003. - № 126. - P. 569-577.